Clinical implications of idiopathic pulmonary fibrosis and lung cancer
Idiopathic pulmonary fibrosis (IPF) is characterized by chronic progressive fibrosis of the lungs of unknown etiology. The prognosis of IPF is poor, with a median survival of 3 to 5 years. Lung cancer is one of the most frequently associated comorbidities of IPF, often resulting in grave outcomes. P...
Saved in:
| Main Authors: | Hongseok Yoo, Man Pyo Chung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sungkyunkwan University School of Medi
2025-03-01
|
| Series: | Precision and Future Medicine |
| Subjects: | |
| Online Access: | http://pfmjournal.org/upload/pdf/pfm-2025-00030.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01) -
Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis
by: Wonseok Whi, et al.
Published: (2025-01-01) -
Pathogenesis and current status of the treatment of lung cancer associated with idiopathic pulmonary fibrosis
by: Yuanyuan Zhang, et al.
Published: (2025-07-01) -
Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01) -
Effect of idiopathic pulmonary fibrosis on postoperative prognosis of patients with non-small cell lung cancer
by: Na LI, et al.
Published: (2024-12-01)